FindTrial
Sign In

Visualization of endolymphatic hydrops in Meniere's disease by MRI

Visualization of endolymphatic hydrops in Meniere's disease by MRI - inner ear enhanced MRI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032563
Enrollment
210
Registered
2018-06-01
Start date
2014-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere&#39

Interventions

Getting MRI 4 hours after intravenous gadodiamide injection.

Sponsors

University of Toyama
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Meniere's disease and delayed endolymphatic hydrops

Exclusion criteria

Exclusion criteria: Contraindication for gadodiamide injection

Design outcomes

Primary

MeasureTime frame
Grading of endolymphatic hydrops using by the MRI 4 hours after gadodiamide injection.—

Countries

Japan

Contacts

Public ContactHideo Shojaku

University of Toyama Department of Otolaryngology

hshojaku@med.u-toyama.ac.jp0764347368

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026